Brand drug manufacturers extend the exclusivity of their drugs beyond the end of their initial exclusivity period by filing multiple additional patents on the same drug, thus creating “patent thickets.”
Pharmaceutical Care
Management Association
505 9th Street NW, 10th Floor, Washington, DC 20004
© 2026 PCMA. All Rights Reserved.